Meta Pixel

News and Announcements

SkyBuys champions contactless transactions in duty free.

  • Published June 15, 2020 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates
The COVID-19 pandemic has impacted almost every aspect of aviation, and when international flights resume, passengers can expect a number of significant changes.

As part of this “new norm”, as travel restrictions are removed, the SkyBuys platform and app will provide passengers with a powerful digital and contactless transaction solution when they shop for duty free during their travels.

And Sydney Airport is forecast to be the busiest international airport in the region. Working with the airport’s concessionaire Heinemann, SkyBuys will ramp up marketing with a variety of offers through its app.

Lockdown has provided SkyBuys with the opportunity to progress its Airbus project, where the world’s leading aircraft manufacturer with over 150 airline clients, now have already demonstrated the application to airline customers.

SkyBuys will continue to work with Airbus as the SkyPaas project moves from testing to live application. Additionally, SkyBuys has secured trial projects with a number of world leading brands, as well as a number of additional retail projects and has also secured a revenue-share agreement in the US with the global travel industry’s leading market research group.

About SkyBuys
Addressing a $75billion global duty-free market, early-stage technology company SkyBuys is improving travel retail. SkyBuys provides convenience, value and choice to international passengers, and new business opportunities to airlines, travel retailers and brand managers. SkyBuys delivered the PoC for its online platform and app with Airbus in Hamburg and is now working with Heinemann at Sydney Airport.

Company Updates

View All
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
Capital Insights
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer

In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]

Read more
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
Capital Insights
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts

As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.

Read more
View All

Join over 45,000+ sophisticated investors

Join Now